Icahn School of Medicine at Mount Sinai, a medical research division of Mount Sinai Health System, has established a $10m fund called i3 Asset Accelerator aimed at commercialising Mount Sinai’s research.
I3 Asset Accelerator will also be supported by Mount Sinai Innovation Partners, the hospital system’s commercialisation operation. The vehicle is still conducting philanthropic fundraising but did not specify a target size.
The fund will offer capital to propel the development of initial-stage projects alongside unspecified contract research organisations. It…
